GGrantIndex
← Search

Operationalizing DNMT1-Targeting to Treat Chemorefractory Pancreatic Cancer

$188,169R21FY2022CANIH

Cleveland Clinic Lerner Com-Cwru, Cleveland OH

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →